1. Calvert AM, Harland SJ, Newell DR (1982) Early clinical studies withcis-diammine-1,1-cyclobutanedicarboxylatoplatinum (II). Cancer Chemother Pharmacol 9: 140–147
2. Harrap KH, Jones M, Wilkinson CR, Clink H, Sparrow S, Mitchley B, Clarke S, Veasey A (1980) Antitumor, toxic and biochemical properties of cisplatin and other platinum complexes. In: Prestayko AW, Crooke ST, Carter SK (eds) Cisplatin, current advances and new developments. Academic Press, New York, pp 193–212
3. Jones RB, Shpall EJ, Shogan J, Moore J, Gockerman J, Peters WP (1988) AFM induction chemotherapy followed by intensive consolidation with autologous bone marrow (ABM) support for advanced breast cancer (abstract). Proc Am Assoc Clin Oncol 8: 8
4. McDonald GB, Sharma P, Matthews DE, (1981) Venoocclusive disease of the liver after bone marrow transplantation: diagnosis, incidence, and predisposing factors. Hepatology 4: 116–122
5. Peters WP, Eder JP, Henner WD, Schryber S, Wilmore D, Finberg R, Schoenfeld D, Bast R, Gargone B, Antman K, Anderson J, Anderson K, Kruskall MS, Schnipper L, Frei E III (1986) High-dose combination alkylating agents with autologous bone marrow support: a phase I trial. J Clin Oncol 4: 646–654